A method for preparing a diaryl monophosphine compound

Through asymmetric arylation reaction catalyzed by chiral phosphoric acid, the problem of using transition metal catalysts in the prior art has been successfully solved, and efficient and green diaryl monophosphine compound synthesis has been achieved, providing a wider application prospect.

CN115703805BActive Publication Date: 2024-11-29SUNSHINE LAKE PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202110923964.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-08-12
Publication Date
2024-11-29
Estimated Expiration
2041-08-12

AI Technical Summary

Technical Problem

The existing methods require the use of transition metal catalysts and activation groups when preparing diaryl monophosphine compounds, resulting in inapplicability and waste of resources, and lack of green and efficient synthesis methods.

Method used

Use chiral phosphoric acid to catalyze the asymmetric arylation reaction of benzenequinone with phosphine-substituted, avoid the use of transition metal catalysts, use trace organic catalysts, and react at specific temperatures and solvent conditions, and pass post-treatment A chiral diaryl monophosphine compound is obtained.

Benefits of technology

High-atomic economy and green and efficient synthesis of chiral diaryl monophosphine compounds without the need for the introduction of activated groups in advance are achieved, reducing resource consumption, improving the applicability of synthesis and product diversity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure QLYQS_1
    Figure QLYQS_1
  • Figure QLYQS_2
    Figure QLYQS_2
  • Figure QLYQS_3
    Figure QLYQS_3
Patent Text Reader

Abstract

The invention relates to a method for preparing a diaryl monophosphine compound, and belongs to the technical field of chemical industry. The method of the invention comprises the following steps: after oxidizing a raw material, performing an asymmetric arylation reaction in the presence of an organic catalyst, and then performing post-treatment to obtain a target compound. The method of the invention avoids the use of a transition metal catalyst, has high atom economy, is green and efficient, and is conducive to application and implementation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a method for preparing a diaryl monophosphine compound, and belongs to the technical field of chemical engineering. Background Art

[0002] Diaryl monophosphine compounds are a class of widely used ligands, most commonly used in palladium-catalyzed carbon-carbon or carbon and heteroatom coupling reactions. In particular, chiral diaryl monophosphine compounds can be used in asymmetric reactions such as asymmetric hydrogenation, asymmetric coupling, asymmetric silylation, etc. Therefore, the preparation of diaryl monophosphine compounds is very critical.

[0003] Among the existing methods, there are two main methods for preparing diaryl monophosphine compounds: one is to construct a diaryl skeleton by metal-catalyzed coupling reaction using a phosphine-substituted monoaromatic substrate, such as the method disclosed in the literature Journal of the American Chemical Society, 2000, 122, 12051-12052 and ACS Catalysis, 2018, 8, 10190-10209; the other is to synthesize diaryl monophosphine compounds by CP coupling or Grignard reagent addition using a compound having a diaryl skeleton, such as the method disclosed in the literature Advanced synthesis & catalysis, 2012, 354, 2031-2037 and Journal of the American Chemical Society, 1995, 117, 9101-9102. However, both methods involve the use of transition metal catalysts and the coupling reaction must first introduce an activating group into the substrate. Therefore, these two types of methods are not very applicable, and it is of great significance to develop greener, more efficient and applicable methods for synthesizing diaryl monophosphine compounds, especially chiral diaryl monophosphine compounds. Summary of the invention

[0004] On the one hand, the present invention aims to provide a more green, efficient and applicable method for synthesizing diaryl monophosphine compounds. After research, the inventors have developed a method for synthesizing chiral diaryl monophosphine compounds by using chiral phosphoric acid to catalyze the asymmetric arylation reaction of phenol or its derivatives with phosphine-substituted p-benzoquinone. The method avoids the use of expensive transition metal catalysts such as palladium, uses a trace amount of organic catalyst, and does not require the introduction of an activating group into the substrate in advance. It has high atom economy, is green and efficient, and has higher applicability.

[0005] A method for preparing a diaryl monophosphine compound (Compound IV) shown in the following formula IV, comprising: reacting Compound II and Compound III in the presence of a catalyst in an organic solvent under certain temperature conditions, and after the reaction is completed, performing post-treatment to obtain Compound IV.

[0006]

[0007] The compound III is shown in the following formula:

[0008]

[0009] Among them, R 1 is alkyl, cycloalkyl, aryl, alkoxy, cycloalkyloxy or aryloxy; R 2 is hydrogen, halogen, alkyl, cycloalkyl, alkoxy, aryl or aryloxy.

[0010] The R 1 or R 2 The hydrogen in the group may be arbitrarily replaced by an alkyl group, an alkoxy group, a halogen group or an oxygen group.

[0011] In the present invention, the alkyl group may be a C1-C6 (1-6 carbon) alkyl group, such as methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, isopropyl or tert-butyl. The alkoxy group may be a C1-C6 (1-6 carbon) alkoxy group, such as methoxy, ethoxy, n-propoxy, n-butoxy, n-pentyl, n-hexyl, isopropoxy or tert-butyloxy. The cycloalkyl group may be a C3-C10 (3-10 carbon) cycloalkyl group, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, etc. The cycloalkyloxy group may be a C3-C10 (3-10 carbon) cycloalkyloxy group, such as cyclopropyloxy, cyclohexyloxy, etc. The aryl group may be a C6-C14 (6-14 carbon) aromatic ring, such as phenyl, benzyl, etc. The aryloxy group may be a C6-C14 (6 carbons to 14 carbons) aromatic ring group, such as a phenoxy group, a benzyloxy group, etc. The halogen group may be fluorine, chlorine, bromine or iodine. The halogen group is preferably chlorine or bromine.

[0012] In some embodiments, R 1 It is a C1-C6 alkyl group, a C3-C10 cycloalkyl group, an aryl group, a C1-C6 alkoxy group, a C3-C10 cycloalkyloxy group or an aryloxy group.

[0013] In some embodiments, R 2 is hydrogen, halogen, C1-C6 alkyl, C3-C10 cycloalkyl, C1-C6 alkoxy, C6-C14 aryl, or C6-C14 aryloxy.

[0014] In some embodiments, a method for preparing compound IV shown in the following formula IV comprises: reacting compound II and compound III in the presence of a catalyst in an organic solvent under certain temperature conditions, and after the reaction is completed, performing post-treatment to obtain compound IV.

[0015]

[0016] The compound III is shown in the following formula: Among them, R 1 is alkyl, cycloalkyl or aryl; R 2 is hydrogen, halogen, alkyl, cycloalkyl, alkoxy, aryl or aryloxy.

[0017] The catalyst may be at least one of the compounds shown in the following structural formula, wherein Ar is 3,5-di(trifluoromethyl)phenyl, 2,4,6-tri(isopropyl)phenyl, 2,4,6-tri(cyclohexyl)-phenyl, 1-naphthyl, 2-naphthyl, 4-biphenyl, 1-pyrene, 9-phenanthrenyl or 9-anthracenyl:

[0018]

[0019] The Ar may be in R configuration or S configuration. In some embodiments, Ar is in R configuration.

[0020] In some embodiments, the catalyst is at least one of the compounds represented by the following structural formulas C1-C6, C7-C9 and C10-C15:

[0021] C1~C6, C7~C9, C10 to C15, wherein, in C1, Ar is 3,5-di(trifluoromethyl)phenyl, in C2, Ar is 1-naphthyl, in C3, Ar is 1-pyrenyl, in C4, Ar is 9-phenanthrenyl, in C5, Ar is 2,4,6-tri(isopropyl)phenyl, in C6, Ar is 2,4,6-tri(cyclohexyl)-phenyl; in C7, Ar is 9-anthryl, in C8, Ar is 9-phenanthrenyl, in C9, Ar is 2,4,6-tri(isopropyl)phenyl; and in C1 to C9, Ar is R configuration; in C10, Ar is 3,5-di(trifluoromethyl)phenyl, in C11, Ar is 4-biphenyl, in C12, Ar is 1-naphthyl, in C13, Ar is 2-naphthyl, in C14, Ar is 9-phenanthrenyl, in C15, Ar is 1-pyrenyl.

[0022] The molar ratio of the catalyst to compound II can be 0.0005:1 to 0.2:1, or 0.001:1-0.2:1, or 0.005:1-0.1:1, or 0.01:1-0.1:1. In some embodiments, the molar ratio of the catalyst to compound II is 0.025:1, or 0.5:1.

[0023] The organic solvent may be at least one of dichloromethane, chloroform, 1,2-dichloroethane, toluene, chlorobenzene and fluorobenzene.

[0024] For each gram of compound II, the amount of the organic solvent may be 5ml-200ml. In some embodiments, for each gram of compound II, the amount of the organic solvent may be 20ml-100ml. In some embodiments, for each gram of compound II, the amount of the organic solvent may be 40ml-100ml. In some embodiments, for each gram of compound II, the amount of the organic solvent may be 50ml-80ml.

[0025] The molar ratio of compound II to compound III can be 1:1-1:1.5, or 1:1.2.

[0026] In the reaction, an additive may be added or not. The additive may be at least one of magnesium sulfate, molecular sieve, silica gel and diatomaceous earth. In some embodiments, it is preferred not to use an additive.

[0027] The temperature condition is -78°C to 25°C. In some embodiments, the temperature condition is not higher than 5°C. In some embodiments, the temperature condition is -35°C. In some embodiments, the temperature condition is -20°C. In some embodiments, the temperature condition is 0°C. In some embodiments, the temperature condition is 20°C.

[0028] The post-treatment includes: concentrating the reaction solution to dryness, and then purifying by column chromatography, crystallization or beating to obtain compound IV. In some embodiments, silica gel column chromatography is used for purification, and the eluent is petroleum ether or a combination of normal hexane and ethyl acetate. In some embodiments, a volume ratio of 1:1-10:1, or 2:1-5:1, or 6:1-8:1 petroleum ether or a combination of normal hexane and ethyl acetate is used as the eluent.

[0029] The aforementioned method for preparing compound IV may further include: in an organic reaction solvent, in the presence of an oxidant, subjecting compound I to an oxidation reaction to prepare compound II, the reaction formula being as shown below, wherein R 1 As defined above:

[0030]

[0031] In some embodiments, the method for preparing compound IV comprises: in an organic reaction solvent, in the presence of an oxidant, compound I undergoes an oxidation reaction to prepare compound II, and the reaction formula is shown below, wherein R 1 As defined above:

[0032]

[0033] The oxidant can be silver oxide, manganese dioxide, cerium ammonium nitrate, iodobenzene diacetate, bis(trifluoroacetyl)iodobenzene or other suitable oxidants.

[0034] The molar ratio of the oxidant to the compound I can be 1:0.5-1:2, or 1:1-1:1.5, or 1:1.2.

[0035] The organic reaction solvent may be at least one of dichloromethane, chloroform, 1,2-dichloroethane, toluene, chlorobenzene and fluorobenzene.

[0036] For each gram of compound I, the amount of the organic reaction solvent can be 5 ml-100 ml, or 10 ml-50 ml, or 80 ml.

[0037] In the oxidation reaction, an auxiliary agent may be added or not. The auxiliary agent may be at least one of magnesium sulfate, molecular sieve, silica gel and diatomaceous earth.

[0038] The molar ratio of the auxiliary agent to the compound I can be 1:0.1-1:5, or 1:1-1:3, or 1:2, or 1:4.

[0039] The reaction temperature of the oxidation reaction can be 0°C-40°C, or 15°C-35°C, or 20°C-30°C.

[0040] The molar ratio of the oxidant to the compound I can be 1:1-1:1.5, or 1:1.2.

[0041] After the oxidation reaction is completed, the reaction solution can be filtered, and the filtrate can be concentrated to dryness under reduced pressure to obtain a crude compound II. The crude compound II obtained can be directly used in the next reaction, or can be purified by column chromatography, crystallization, salt formation, etc. to obtain a product with higher purity; preferably, the crude product is directly used in the next reaction.

[0042] On the other hand, according to some embodiments of the present invention, the aforementioned compound IV can be subjected to a protecting group reaction, and then subjected to a reduction reaction and a substitution reaction to obtain a variety of chiral diaryl monophosphine compounds. Therefore, the present invention also provides a method for preparing a chiral diaryl monophosphine compound.

[0043] A method for preparing a diaryl monophosphine compound comprises: compound IV and a protecting agent undergo a protecting group reaction to prepare compound V; compound V and a reducing agent undergo a reduction reaction to prepare compound VI; compound VI undergoes a reaction to prepare compound VII; the reaction formula is as follows:

[0044]

[0045] Wherein, * represents the chiral axis; R 1 , R 2 As defined above; R 3 It may be an alkyl group, a cycloalkyl group, an alkenyl group, a benzyl group, an alkyl acyl group, a benzoyl group or a phenylacetyl group.

[0046] In some embodiments, a method for preparing a diaryl monophosphine compound comprises: compound IV and a protecting agent undergo a protecting group reaction to prepare compound V; compound V and a reducing agent undergo a reduction reaction to prepare compound VI; compound VI undergoes a reaction to prepare compound VII; the reaction formula is as follows:

[0047]

[0048] Wherein, * represents the chiral axis; R 1 , R 2 and R 3 As defined above; R 4 and R 5 are independently aryl or heteroaryl which may be substituted by alkyl, alkoxy, halogen or oxygen; or R 4 , R 5 Together with phosphorus, it forms a four-membered ring to a seven-membered ring which may be substituted by alkyl, alkoxy, halogen or oxygen.

[0049] The R 1 , R 2 , R 3 , R 4 and R 5 The hydrogen in the group may be arbitrarily replaced by an alkyl group, an alkoxy group, a halogen group or an oxygen group.

[0050] In some embodiments, R 3 is C1-C6 alkyl, C3-C10 cycloalkyl, C1-C6 alkenyl, benzyl, C1-C6 alkyl acyl, benzoyl or phenylacetyl. 3 is a C1-C6 alkyl, a C3-C10 cycloalkyl, a C1-C6 alkenyl or a benzyl. 3 is methyl, ethyl, allyl, cyclohexyl, benzyl, benzoyl or phenylacetyl. 3 is methyl, ethyl, allyl, cyclohexyl or benzyl.

[0051] In some embodiments, R 4 and R 5 are independently phenyl, p-methoxyphenyl, p-nitrophenyl, pentafluorophenyl, 3,5-ditrifluoromethylphenyl or 2,4,6-trimethylphenyl. 4 , R5 Together with phosphorus, it forms a six-membered ring.

[0052] The protecting agent may be trimethylsilyldiazomethane, methyl iodide, benzyl bromide, allyl bromide or other suitable hydroxyl protecting groups.

[0053] The protecting group addition reaction can be carried out in a reaction solvent such as methanol, toluene, etc.

[0054] The reaction temperature of the protecting group addition reaction can be controlled at -5°C-40°C, or 0°C-30°C.

[0055] The reducing agent may be a combination of lithium aluminum tetrahydride and trimethylsilyl chloride.

[0056] The reaction temperature of the reduction reaction can be controlled to be -5°C-40°C, or 0°C-30°C. The reaction solvent of the reduction reaction can be tetrahydrofuran, 2-methyltetrahydrofuran or other suitable solvents.

[0057] In some embodiments, compound VI can be prepared by reacting compound VII with a halogenated aromatic compound in the presence of a catalyst and a base under heating conditions.

[0058] The present invention obtains a chiral monophosphine diaryl compound by using a trace amount of organic catalyst without the need to introduce an activating group in advance, has high atom economy, is green and efficient, and the obtained compound can be further reacted to obtain a variety of novel diaryl monophosphine ligands, thus having a relatively broad application prospect. DETAILED DESCRIPTION

[0059] In order to enable those skilled in the art to better understand the technical solution of the present invention, some non-limiting embodiments are further disclosed below to further illustrate the present invention in detail.

[0060] The reagents used in the present invention can be purchased from the market or prepared by the method described in the present invention.

[0061] In the present invention, g: gram; mL: milliliter; mmol: millimole; ℃: degree Celsius; h: hour; min: minute; ℃: degree Celsius; LCMS or LC-MS means liquid chromatography-mass spectrometry; HRMS (ESITOF): high resolution mass spectrometry (electrospray time-of-flight mass spectrometry); TLC: thin layer chromatography; Rf: relative shift; DCM or CH2Cl2: dichloromethane, DCE: 1,2-dichloroethane; DIPEA: N,N-diisopropylethylamine; eq: equivalent, calculated by molar ratio. PE / EA: petroleum ether / ethyl acetate; in the present invention, the eluent is calculated by volume ratio. t major Indicates the main product peak time, t minor Indicates the peak time of the product that is less than the main product.

[0062] ee (enantiomeric excess) value calculation method: ee = ([R] - [S]) / ([R] + [S]) * 100%, where R represents the content of R-configuration product, S represents the content of S-configuration product, and the ee of other configuration products is calculated using a similar method.

[0063] In the present invention, room temperature refers to ambient temperature, which is 0°C-30°C or 0°C-25°C or 15°C-25°C or 20°C-28°C.

[0064] Example 1: Reaction Condition Screening

[0065]

[0066] Compound I-01 (0.10 mmol), Ag2O (27.8 mg, 0.12 mmol) and MgSO4 (36.1 mg, 0.30 mmol) were added to a reaction solvent (2.0 mL) and reacted at 25°C for 2 h. After the reaction was completed, the mixture was filtered and the filtrate was concentrated under reduced pressure to obtain II-01. The obtained II-01, 2-naphthol (17.3 mg, 0.12 mmol), catalyst (C1-C15, 0.005 mmol, 5 mol%) and additive (MgSO4: 36.1 mg, 0.30 mmol, or 4 molecular sieves, or no additive) were added to a solvent (2 mL) and reacted at -20°C. After the reaction was completed, the reaction solution was concentrated under reduced pressure and the residue was purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 3 / 1, volume ratio) to obtain compound IV-01. The reaction conditions and results are shown in Table 1 below, wherein the reaction temperature of reaction No. 1 is room temperature 25°C, the reaction temperature of reaction No. 2 is 0°C, the reaction temperature of reaction No. 25 is -35°C, and the reaction temperature of reaction No. 26 is -78°C; the amount of catalyst used in reaction No. 27 is 0.0025 mmol (2.5 mol%), and a negative ee value indicates that the main product is an S configuration.

[0067] Table 1: Reaction conditions and results

[0068]

[0069] Example 2: Reactions with different substrates

[0070]

[0071] Compound I (0.30 mmol), Ag2O (83.4 mg, 0.36 mmol) and MgSO4 (108.3 mg, 0.90 mmol) were added to DCM (6.0 mL) and reacted at 25°C for 2 h. After the reaction was completed, the mixture was filtered and the filtrate was concentrated under reduced pressure to obtain compound II. Then, the obtained compound II, 2-naphthol (51.9 mg, 0.36 mmol) and catalyst C7 (5.0 mg, 0.0075 mmol, 2.5 mol%) were added to DCE (6 mL) and reacted at -35°C. After the reaction was completed, the reaction solution was concentrated under reduced pressure and the residue was purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 3 / 1, volume ratio, see Table 4) to obtain compound IV. The reaction formula is shown above, where * represents the chiral axis. The substrate and the result are shown in Table 2 below.

[0072] Table 2: Reaction results of different substrates

[0073] Serial number <![CDATA[R 1 ]]> Yield of product IV (%) Product IV ee (%) 28 Ethyl 96 95 29 Isopropyl 79 92 30 n-Butyl 87 90.5 31 Benzyl 77 91

[0074] Example 3: Reactions with different substrates

[0075]

[0076] Compound I-02 (0.30 mmol), Ag2O (83.4 mg, 0.36 mmol) and MgSO4 (108.3 mg, 0.90 mmol) were added to DCM (6.0 mL) and reacted at 25°C for 2 h. After the reaction was completed, the filtrate was filtered and concentrated under reduced pressure to obtain compound II-02. Compound II-02, compound III (0.36 mmol) and catalyst C7 (5.0 mg, 0.0075 mmol, 2.5 mol%) were added to DCE (6 mL) and reacted at -35°C. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 5 / 1 to 2 / 1, volume ratio, see Table 4 below for details) to obtain compound IV; the reaction formula is shown above, where * represents the chiral axis. The substrate and results are shown in Table 3 below.

[0077] Table 3: Reaction results of different substrates

[0078]

[0079]

[0080] Table 4: Structural formula and structural confirmation data of some compounds in Examples 1 to 3

[0081]

[0082]

[0083]

[0084]

[0085]

[0086]

[0087]

[0088]

[0089] Example 4

[0090]

[0091] Compound I-06 (105.9 mg, 0.34 mmol, 1.0 eq), Ag2O (94.9 mg, 0.41 mmol, 1.2 eq) and MgSO4 (123.2 mg, 1.02 mmol, 3.0 eq) were added to DCM (7.0 mL) and reacted at 25 °C for 2 h. After the reaction was completed, the filtrate was filtered and concentrated under reduced pressure to obtain compound II-06, which was directly used in the next step. The obtained compound II-06, 2-naphthol (59.1 mg, 0.0.41 mmol, 1.2 eq) and catalyst C7 (5.0 mg, 0.0075 mmol, 2.5 mol%) were added to DCM (7 mL), and the reaction was carried out at -35 ° C for 26 h. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate = 3 / 1, volume ratio) to obtain compound IV-06: white solid, 38.3 mg, yield 25%, ee: 18%; Rf = 0.34 (petroleum ether / ethyl acetate = 1 / 1, volume ratio), melting point mp: 247.3 ° C; (c = 0.5, ethyl acetate); 1 H NMR (400MHz, DMSO-d6): δ10.71(s,1H),9.17(s,1H),8.45(s,1H),7.50-7.34(m,7H),7.11-6.99(m,6H),6.95-6.74(m,5H); 31 P NMR (162MHz, CDCl3) δ: 36.5 (s); 13 C{ 1H}NMR (151MHz, CDCl3): δ155.4,155.3,152.5,148.34,148.26,134.0,133.7,133.2,132. 9,132.5,132.3,132.2,132.0,131.6,131.5,131.4,131.0,130.6,130.52,130.50,129.3, 128.8,128.5,127.74,127.65,127.5,127.3,126.8,126.7,126.31,126.25,125.2,124.2 ,121.7,121.4,117.7,117.3,117.2,115.9,115.8,115.1,114.4; HRMS(ESITOF)m / z:[M+H] + Calculate (C 28 H 22 O4P), 453.1250; found 453.1228; enantiomeric excess ee was determined by normal phase HPLC: FLM Chiral NY (2) chiral column, n-hexane / ethanol = 30:70, flow rate 0.5 mL / min, t major =7.64min,t minor =12.75min, wavelength λ=210nm.

[0092] Example 5

[0093]

[0094] Compound I-02 (2.21 g, 9.0 mmol), Ag2O (2.50 g, 10.80 mmol) and MgSO4 (3.25 g, 27.0 mmol) were added to DCM (180 mL) and reacted at 25°C for 2 h. After the reaction was completed, the filtrate was filtered and concentrated under reduced pressure to obtain compound II-02, which was directly used in the next step. The obtained compound II-02, 2-naphthol (1.56 g, 10.80 mmol) and catalyst C7 (30.0 mg, 0.045 mmol, 0.5 mol%) were added to DCE (180 mL) and reacted at -35°C for 44.5 h. After the reaction was completed, the reaction solution was concentrated under reduced pressure and then purified by silica gel column chromatography (petroleum ether / ethyl acetate = 5 / 1, volume ratio) to obtain compound IV-02: white solid, 3.29 g, yield 94%, ee: 94%, and was confirmed to be compound IV-02 after detection.

[0095] Example 6

[0096]

[0097] Compound IV-02 (0.5 g, 1.29 mmol) was dissolved in methanol (10 mL), and TMSCHN2 (2.0 M hexane solution, 15 mL, 29.6 mmol) was added dropwise at 0°C; after the addition, the mixture was reacted at 0°C for 5 min, and then the reaction system was heated to room temperature 25°C and continued to react for 24 h. After the reaction was completed, the mixture was concentrated under reduced pressure (33°C) and the obtained crude product was purified by silica gel column chromatography (CH2Cl2 / MeOH=100 / 1~40 / 1, volume ratio) to obtain compound V-01: 527.3 mg, yield: 95%, ee: 95%, white solid; Rf=0.38 (CH2Cl2 / MeOH=20 / 1), melting point mp: 115.5°C; (c = 0.5, CH2Cl2); 1 H NMR (400MHz, CDCl3): δ7.85 (d, J=9.0Hz, 1H), 7.81-7.74 (m, 1H), 7.34-7.24 (m, 3H), 7.19 (dd, J=9.1, 5.5Hz, 2H), 7.10-7.01 (m ,1H),3.93(s,3H),3.82(s,3H),3.81-3.71(m,2H),3.70-3.60(m,1H),3.51(s,3H),3.43-3.36(m,1H),0.87(q,J=7.3Hz,6H); 31 P NMR (162MHz, CDCl3) δ: 16.0 (s); 13 C{ 1 H}NMR (151MHz, CDCl3): δ156.63,156.62,153.8,152.2,152.0,133.8,131.3,131.2,128.9,128.7,127.7,126.1,124.6,123.2,120.74,120.71, 118.6,117.37,117.36,117.31,113.4,112.1,112.0,62.4,62.3,62.10 ,62.06,56.9,56.6,56.5,15.73,15.68,15.64; HRMS(ESITOF)m / z:[M+H] + Calculate (C 23 H 28 O6P), 431.1618; found: 431.1621; enantiomeric excess ee was determined by HPLC: FLM Chiral ND (2) column, n-hexane / ethanol = 90:10, flow rate: 0.5 mL / min, t major =18.63min,t minor =15.73min,λ=210nm).

[0098] Under nitrogen protection, lithium aluminum tetrahydride (352.7 mg, 9.29 mmol) was added to 5 ml of tetrahydrofuran and the temperature was lowered to 0°C; trimethylsilyl chloride (1.01 g, 9.29 mmol) was slowly added dropwise, and the mixture was stirred for 30 min after the addition was complete; then a tetrahydrofuran solution of compound IV-01 (0.5 g, 1.16 mmol) was added dropwise within 30 minutes; after the addition was complete, the reaction system was slowly heated to room temperature and the reaction was continued for 16 h. The reaction system was cooled to 0°C, ethyl acetate (5 mL) was added to quench the reaction, and then dilute hydrochloric acid (1 M, 10 mL) was added; the reaction system was extracted with ethyl acetate (2×10 mL), the organic phase was washed with saturated brine (30 mL), and the organic phase was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain compound VI-01: light yellow solid, 385.9 mg, yield>99%, ee: 84%; can be used for the next step reaction; Rf=0.33 (petroleum ether / ethyl acetate=5 / 1), melting point mp: 163.1°C; (c = 0.5, CH2Cl2); 1 H NMR (400MHz, CDCl3): δ7.92(d,J=9.0Hz,1H),7.83(dd,J=5.4,4.0Hz,1H),7.39(d,J=9.0Hz,1H),7.3 6-7.28(m,2H),7.25-7.19(m,1H),6.93(dt,J=8.9,5.9Hz,2H),3.89(d,J=14.4Hz,6H),3.58(s,3H); 31 P NMR(162MHz, CDCl3)δ:-154.8(s); 13 C{ 1 H}NMR (151MHz, CDCl3): δ154.53,154.49,154.0,152.26,152.25,132.9,130.22,130.16,129.5,129.1,128.04,127. 96,126.5,124.6,123.5,122.1,122.0,121.2,121.1,113.8,111.5,109.5,56.8,56.6,56.0; HRMS(ESITOF)m / z:[M+H] + Calculate (C 19 H 20 O3P), 327.1145; found: 327.1140; enantiomeric excess ee was determined by HPLC: FLM Chiral MD (2) column, n-hexane / ethanol = 70:30, flow rate: 0.5 mL / min, t major =9.44min,tminor =8.94min,λ=210nm.

[0099] Example 7

[0100]

[0101] Under nitrogen protection, the catalyst PdCl2 (dppf) (40.4 mg, 0.055 mmol), diisopropylethylamine (285.2 mg, 2.21 mmol) and iodide ArI (1.65 mmol) were dissolved in 10 ml of acetonitrile, and compound VI-01 (180.0 mg, 0.552 mmol) was added, and the reaction mixture was heated to 80 ° C for 2 h; after the reaction was completed, the reaction solution was concentrated under reduced pressure and then purified by silica gel column chromatography to obtain the product, eluent: petroleum ether / ethyl acetate = 5 / 1, volume ratio.

[0102] Iodobenzene was used as the iodide to obtain compound VII-01: Rf = 0.33 (petroleum ether / ethyl acetate = 5 / 1), white solid, 87.5 mg, yield 33%, ee: 90% ee; melting point mp: 196.3°C; (c = 0.5, CH2Cl2); 1 H NMR (400MHz, CDCl3): δ7.90 (d, J = 9.0Hz, 1H), 7.86-7.79 (m, 1H), 7.36-7.20 (m, 9H) ,7.15-7.12(m,6H),6.91(d,J=8.9Hz,1H),3.59(s,3H),3.50(s,3H),3.29(s,3H); 31 P NMR (162MHz, CDCl3) δ: 13.0 (s); 13 C{ 1 H}NMR (151MHz, CDCl3): δ156.5,156.4,154.27,154.25,152.1,152.0,138.3, 138.2,137.1,137.0,134.9,133.71,133.70,132.6,132.4,132.3,132.2,128 .0,127.5,127.4,127.21,127.17,127.0,126.9,126.0,125.1,124.8,123.2, 121.8,121.7,114.8,112.7,112.0,56.7,55.7,55.2; HRMS(ESITOF)m / z:[M+H] + Calculate (C 31 H 28O3P), 479.1771; found: 479.1776; enantiomeric excess ee was determined by HPLC: FLM Chiral ND (2) column, n-hexane / ethanol = 70:30, volume ratio, flow rate 0.5 mL / min, t major =7.83min,t minor =8.60min,λ=210nm.

[0103] Using 4-methoxyiodobenzene as iodide, compound VII-02 was obtained: Rf = 0.21 (petroleum ether / ethyl acetate = 5 / 1), yellow solid, 146.5 mg, yield: 44%, ee: 90%; melting point mp: 138.8°C; (c = 0.5, EA); 1 HNMR (400MHz, CDCl3): δ7.88(d,J=9.0Hz,1H),7.84-7.78(m,1H),7.34-7.18(m,6H),7.14-7.01(m,3H),6.91(d,J=8 .9Hz,1H),6.79(d,J=7.9Hz,2H),6.68(d,J=8.3Hz,2H),3.76(d,J=22.6Hz,6H),3.55(d,J=12.4Hz,6H),3.37(s,3H); 31 P NMR (162MHz, CDCl3) δ: 14.7 (s); 13 C{ 1 H}NMR (151MHz, CDCl3): δ156.43,156.41,154.24,154.23,152.1,152.0,134.4,134.3,134.2,133.7,133.6,129.1,128.6,127.9, 126.0,125.1,123.1,114.6,113.22,113.17,113.0,112.91,112.85,112.0,56.7,55.9,55.4,55.1,55.0; HRMS(ESITOF)m / z:[M+H] + Calculate (C 33 H 32 O5P), 539.1982; found: 539.1975; enantiomeric excess ee was determined by HPLC: FLM ChiralMX (2) column, n-hexane / ethanol = 70:30, flow rate: 0.5 mL / min, t major =14.03min,t minor =18.23min,λ=210nm.

[0104] Example 8

[0105]

[0106] Phorone (i.e., diisopropylacetate, 1.0 mL, 6.43 mmol) and compound VI-01 (379.0 mg, 1.16 mmol) were added to a 10 ml sealed tube, plugged with a polytetrafluoroethylene stopper, and heated to 160°C for reaction for 21 hours; then the system was cooled to room temperature, concentrated under reduced pressure to remove excess phorone, and then purified by silica gel column chromatography (petroleum ether / ethyl acetate = 5 / 1) to obtain compound VII-03: 356.2 mg, yield: 66%, ee: 84%, white solid; Rf = 0.24 (petroleum ether / ethyl acetate = 5 / 1), melting point mp: 200.2°C; (c = 0.5, ethyl acetate); 1 H NMR (400MHz, CDCl3): δ7.89(d,J=9.0Hz,1H),7.82-7.76(m,1H),7.34-7.21(m,3H),7.09(d,J=9.0Hz,2H),6.96(d,J=8.9Hz,1H),3.85(s,6H),3. 54(s,3H),3.06(dd,J=19.8,13.1Hz,2H),2.12(ddd,J=41.2,13.6,5.6Hz,2H),1.11-0.97(m,6H),0.81(d,J=9.0Hz,3H),0.69(d,J=22.3Hz,3H); 31 P NMR (162MHz, CDCl3) δ: 8.9 (s); 13 C{ 1 H}NMR (151MHz, CDCl3): δ155.07,155.05,153.39,153.37,152.53,152.46,1 37.7,137.4,133.8,133.7,128.8,128.6,127.8,126.3,126.0,125.52,125.4 9,122.9,122.0,114.1,112.5,109.1,56.7,55.7,54.7,54.4,54.2,35.1,34. 94,34.88,34.7,34.4,34.1,33.8,33.5,29.4,28.8; HRMS(ESITOF)m / z:[M+H] + Calculate (C 28 H 34O4P), 465.2189; found: 465.2185; enantiomeric excess ee was determined by HPLC: FLM Chiral MD (2) column, n-hexane / ethanol = 90:10, volume ratio, flow rate: 0.5 mL / min, t major =12.17min,t minor =11.55min,λ=210nm.

[0107] The method of the present invention has been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein based on the content of the present invention to implement and apply the technology of the present invention. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters to implement the technology of the present invention. It is particularly important to point out that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention.

Claims

1. A method for preparing compound IV, comprising: Compound II and compound III react in the presence of a catalyst in an organic solvent under certain temperature conditions. After the reaction is completed, compound IV is obtained through post-treatment. The compound III is shown in the following formula: Among them, R 1 is methoxy, ethoxy, isopropoxy, n-propoxy, n-butoxy, phenyl or benzyloxy; R 2 is hydrogen, methyl, ethyl, phenyl, benzyl, methoxy, ethoxy, n-propoxy, n-butoxy or benzyloxy; The catalyst is at least one of the compounds shown in the following structural formula: wherein Ar is 3,5-di(trifluoromethyl)phenyl, 2,4,6-tri(isopropyl)phenyl, 2,4,6-tri(cyclohexyl)phenyl, 1-naphthyl, 2-naphthyl, 4-biphenyl, 1-pyrenyl, 9-phenanthryl or 9-anthryl.

2. The method according to claim 1, wherein the molar ratio of the catalyst to the compound II is 0.0005:1 to 0.2:

1.

3. The method according to claim 1 or 2, wherein the organic solvent is at least one of dichloromethane, chloroform, 1,2-dichloroethane, toluene, chlorobenzene and fluorobenzene.

4. The method according to claim 1, wherein an additive is optionally added during the reaction, and the additive is selected from at least one of magnesium sulfate, molecular sieves, silica gel and diatomaceous earth. The method according to claim 1 , wherein the temperature condition is -78° C. to 25° C.

6. The method according to claim 1, wherein the post-processing comprises: The reaction solution was concentrated to dryness and then subjected to column chromatography, with the eluent being petroleum ether or a combination of n-hexane and ethyl acetate in a volume ratio of 1:1-10:

1.

7. The method according to claim 1, further comprising: In a reaction solvent, in the presence of an oxidant, compound I undergoes an oxidation reaction to prepare compound II. The oxidant is silver oxide, manganese dioxide, cerium ammonium nitrate, iodobenzene diacetate or bis(trifluoroacetyl)iodobenzene.

8. The method according to claim 7, comprising at least one of the following conditions: The reaction solvent is at least one of dichloromethane, chloroform, 1,2-dichloroethane, toluene, chlorobenzene and fluorobenzene; In the oxidation reaction, an auxiliary agent is optionally added, and the auxiliary agent is selected from at least one of magnesium sulfate, molecular sieve, silica gel and diatomaceous earth; or The reaction temperature of the oxidation reaction is 0°C-40°C.

9. A preparation method comprising: Compound IV is prepared according to any one of claims 1 to 8, and compound IV is reacted with a protecting reagent to obtain compound V; Compound V is subjected to a reduction reaction with a reducing agent to prepare compound VI Wherein, * represents the chiral axis; R 3 is methyl, ethyl, allyl, cyclohexyl or benzyl.

10. The method according to claim 9, wherein the protecting agent is trimethylsilyldiazomethane, methyl iodide, benzyl bromide or allyl bromide; and / or the reducing agent is a combination of lithium aluminum tetrahydride and trimethylsilyl chloride.